[
    [
        {
            "time": "2022-10-15",
            "original_text": "AbbVie Stock Dropped After FDA Warning. Analysts Say Selloff Is Overblown.",
            "features": {
                "keywords": [
                    "AbbVie",
                    "FDA Warning",
                    "Selloff",
                    "Overblown"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "AbbVie Stock Dropped After FDA Warning. Analysts Say Selloff Is Overblown.",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2022-10-15",
            "original_text": "7 Healthcare Stocks to Buy Before $3.5 Trillion Floods In",
            "features": {
                "keywords": [
                    "Healthcare Stocks",
                    "Buy",
                    "$3.5 Trillion"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "7 Healthcare Stocks to Buy Before $3.5 Trillion Floods In",
                "Correlation": 5,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2022-10-15",
            "original_text": "AbbVie (ABBV) Stock Down as FDA Issues New Warning for Rinvoq",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Stock Down",
                    "FDA",
                    "Warning",
                    "Rinvoq"
                ],
                "sentiment_score": -0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "AbbVie (ABBV) Stock Down as FDA Issues New Warning for Rinvoq",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2022-10-15",
            "original_text": "FDA Orders Warnings on Pfizer, Lilly, AbbVie JAK Drug Labels",
            "features": {
                "keywords": [
                    "FDA",
                    "Warnings",
                    "Pfizer",
                    "Lilly",
                    "AbbVie",
                    "JAK Drugs"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "FDA Orders Warnings on Pfizer, Lilly, AbbVie JAK Drug Labels",
                "Correlation": 8,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2022-10-15",
            "original_text": "FDA Hits JAK inhibitors With Heart Safety, Cancer Warnings: All You Need To Know",
            "features": {
                "keywords": [
                    "FDA",
                    "JAK inhibitors",
                    "Heart Safety",
                    "Cancer Warnings"
                ],
                "sentiment_score": -0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "FDA Hits JAK inhibitors With Heart Safety, Cancer Warnings: All You Need To Know",
                "Correlation": 7,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2022-10-15",
            "original_text": "3 Biotech Stocks That Are Too Cheap to Ignore",
            "features": {
                "keywords": [
                    "Biotech Stocks",
                    "Cheap",
                    "Ignore"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "biotech"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "3 Biotech Stocks That Are Too Cheap to Ignore",
                "Correlation": 4,
                "Sentiment": 9,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2022-10-15",
            "original_text": "Stall Speed? Jobs Gut Punch, Taiwan Worries, Mu Variant, Trading AbbVie",
            "features": {
                "keywords": [
                    "Stall Speed",
                    "Jobs",
                    "Taiwan",
                    "Mu Variant",
                    "Trading",
                    "AbbVie"
                ],
                "sentiment_score": -0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Stall Speed? Jobs Gut Punch, Taiwan Worries, Mu Variant, Trading AbbVie",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        }
    ]
]